Radovich Peter's Form 4 filing
Mirum Pharmaceuticals, Inc. (MIRM) · filed Mar 18, 2024
- Accession no.
- 0001415889-24-008322
- Filed
- Mar 18, 2024
- Trade date
- Jan 9, 2023
- Filing delay
- 434 daysLate
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market sales total $28.4K. It was filed 434 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Radovich PeterCIK 0001650131 | Officer (PRESIDENT AND COO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | Common Stock | SSaleDisposed | −1,379 | $20.62 | −$28,434.98 | 33,316 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.